El Salvador inks deal with Pfizer for 4.4 million COVID-19 vaccine doses


  • World
  • Wednesday, 05 May 2021

A healthcare worker shows a vial of Pfizer/BioNTech coronavirus disease (COVID-19) vaccine in Rio de Janeiro, Brazil May 4, 2021. REUTERS/Ricardo Moraes

SAN SALVADOR (Reuters) - El Salvador's president Nayib Bukele said on Twitter on Tuesday night that the Central American nation has signed an agreement with Pfizer Inc for 4.4 million COVID-19 vaccine doses.

"With this purchase, we guarantee uninterrupted immunization for our entire target population," said Bukele.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Chinese young scientists urge global solidarity to advance sustainability agenda
Weekly storage of natural gas in U.S. increases: EIA
South Africa's manufacturing output contracts in Q1
Kenya hosts China-Africa economic trade expo amid growing Sino-African ties
African leaders endorse plan to boost soil health, fertilizer use
Zambia launches blue economy strategy to drive sustainable development
Zambian VP calls for action to reduce maternal, neonatal deaths
Roundup: Chinese agricultural technologies attract visitors at Africa fertilizer expo
Uganda says geopolitical tensions, climate change key risk factors to revenue collection
Flooding, landslides affect nearly 1 mln in E. Africa: UN

Others Also Read